Noble Life Sciences is a contract research organization (CRO) that provides a full continuum of preclinical drug, vaccine and medical device development services, from initial product discovery to GLP-compliant studies. Our services are designed to help you advance from concept to clinic faster and more efficiently.
Noble's state-of-the-art facilities are located in Sykesville, MD in the BioHealth Capital Region. We offer integrated in vitro and in vivo services, including cellular and animal disease model development and experimental design, efficacy, toxicity, biodistribution and product release studies in both small and large animals. Managed by industry experts with years of experience in animal care, Noble's vivarium services group is ready to support your in vivo R&D: we provide custom housing, husbandry, and breeding; facility and program management; and high-level implementation of preclinical drug development services. Noble also offers custom antibody production services as well as tissue and animal sourcing. With an emphasis on quality, our proof-of- concept studies, early safety assessments and other pre-IND services are sure to provide a strong scientific foundation for your preclinical decisions. Noble’s key advantages are our deep expertise and the years of experience of our scientific team, who bring their insights to optimize and expedite our customers’ preclinical studies. With our quality control and expertise in cell- & animal-based models, you can trust Noble scientists to help lead and support your development programs through each phase of the preclinical process.
Noble's state-of-the-art facilities are located in Sykesville, MD in the BioHealth Capital Region. We offer integrated in vitro and in vivo services, including cellular and animal disease model development and experimental design, efficacy, toxicity, biodistribution and product release studies in both small and large animals. Managed by industry experts with years of experience in animal care, Noble's vivarium services group is ready to support your in vivo R&D: we provide custom housing, husbandry, and breeding; facility and program management; and high-level implementation of preclinical drug development services. Noble also offers custom antibody production services as well as tissue and animal sourcing. With an emphasis on quality, our proof-of- concept studies, early safety assessments and other pre-IND services are sure to provide a strong scientific foundation for your preclinical decisions. Noble’s key advantages are our deep expertise and the years of experience of our scientific team, who bring their insights to optimize and expedite our customers’ preclinical studies. With our quality control and expertise in cell- & animal-based models, you can trust Noble scientists to help lead and support your development programs through each phase of the preclinical process.
Location: United States, Maryland, Woodbine
Employees: 11-50
Founded date: 2010
Investors 1
| Date | Name | Website |
| - | BroadOak C... | broadoak.c... |
Mentions in press and media 3
| Date | Title | Description |
| 27.08.2018 | Wednesday: See how the pieces of Baltimore’s biohealth community fit together | A startup can begin with a single idea, but there are many considerations toward helping it grow. For early-stage companies in biohealth, there are some specific considerations. Lab space is needed for research. It’s necessary to be aware o... |
| 19.05.2014 | Morgan State dean, personality assessment app among TEDCO honors | TEDCO, the state-backed technology investment fund, honored two startups, a medical technology firm founder and an educator Thursday. The organization’s fourth annual ICE Awards, held at the Columbia Sheraton, delivers awards in innovation,... |
| 30.06.2011 | BlackRock BioCapital Launches | The founders of Noble Life Sciences, a Gaithersburg, Maryland-based preclinical research services company, have launched a new investment capital fund. BlackRock BioCapital will focus on creating and funding early stage technology-oriented ... |